Statins decrease bone turnover in postmenopausal women: a cross‐sectional study

Stimulation of Bone Formation in Vitro and in Rodents by Statins

1999 • 1,751 citations

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

1998 • 1,174 citations

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1995 • 1,039 citations

Drug Treatment of Lipid Disorders

1999 • 863 citations

HMG-CoA Reductase Inhibitors and the Risk of Fractures

2000 • 452 citations

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

2000 • 424 citations

Use of Statins and Risk of Fractures

2001 • 280 citations

Effect of pravastatin on frequency of fracture in the LIPID study: secondly analysis of a randomised controlled trial

2001 • 219 citations

Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies

1995 • 178 citations

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.

1993 • 169 citations

HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients*

2000 • 161 citations

Effect of Statins on Bone Mineral Density and Bone Histomorphometry in Rodents

2001 • 159 citations

Drug-Induced Bone Loss

2000 • 103 citations

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1993 • 99 citations

Chronic Intravenous Aminobisphosphonate Therapy Increases High-Density Lipoprotein Cholesterol and Decreases Low-Density Lipoprotein Cholesterol

2000 • 94 citations

Thiazides and Bone Mineral Density in Elderly Men and Women

1994 • 94 citations

Statin drugs and the risk of fracture.

2000 • 80 citations

Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence

1987 • 68 citations

HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients

2000 • 57 citations

Use of Bone Alkaline Phosphatase to Monitor Alendronate Therapy in Individual Postmenopausal Osteoporotic Women

1999 • 52 citations

Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.

1996 • 42 citations